Tyler A. Shugg, PharmD, PhD

Dr. Shugg completed Doctor of Pharmacy training and later graduate training at the Purdue University College of Pharmacy, receiving a PhD in Clinical Pharmaceutical Sciences. As a graduate student, Dr. Shugg’s research explored drug- and disease-related mechanisms of potassium channel dysregulation and ventricular arrhythmogenesis using laboratory-based approaches. Following completion of his graduate training, Dr. Shugg pursued fellowship training at the University of Michigan College of Pharmacy focused on cardiovascular pharmacogenetics, enabling him to gain complementary expertise in clinical research approaches. Dr. Shugg then joined the Division of Clinical Pharmacology at the Indiana University School of Medicine as a postdoctoral fellow to support the institutional Precision Health Initiative. Upon completion of his fellowship, he was promoted to Assistant Research Professor. Dr. Shugg’s independent research program is focused on the discovery and implementation of precision medicine approaches, including pharmacogenetics and management of drug-drug interactions, to enhance medication outcomes, particularly in patients with cancer. Dr. Shugg has been with the Division of Clinical Pharmacology as Assistant Research Professor of Medicine since January 2022.